NAV2-AS2 and SEC24B-AS1 are prognostic biomarkers for lung adenocarcinoma (He and Zuo, 2019) and non-small cell lung cancer (Yang et al., 2020), respectively. This evidence concerns the gene SEC24B and lung adenocarcinoma.